Wuxi AppTec Co Ltd (WUXAY)
4.45
+0.04
(+0.91%)
USD |
OTCM |
Apr 29, 16:00
Wuxi AppTec Cash from Financing (TTM): -557.20M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -557.20M |
| September 30, 2023 | -544.73M |
| June 30, 2023 | -390.80M |
| March 31, 2023 | -229.41M |
| December 31, 2022 | -190.23M |
| September 30, 2022 | -121.85M |
| June 30, 2022 | -449.40M |
| March 31, 2022 | -242.17M |
| December 31, 2021 | -267.00M |
| September 30, 2021 | -293.92M |
| June 30, 2021 | 1.625B |
| March 31, 2021 | 1.436B |
| December 31, 2020 | 1.433B |
| Date | Value |
|---|---|
| September 30, 2020 | 1.562B |
| June 30, 2020 | 88.23M |
| March 31, 2020 | 204.37M |
| December 31, 2019 | 225.54M |
| September 30, 2019 | 887.40M |
| June 30, 2019 | 667.71M |
| March 31, 2019 | 1.076B |
| December 31, 2018 | 1.056B |
| September 30, 2018 | 308.75M |
| June 30, 2018 | 416.52M |
| March 31, 2018 | -83.11M |
| December 31, 2017 | -99.93M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-557.20M
Minimum
Dec 2023
1.625B
Maximum
Jun 2021
254.84M
Average
-121.85M
Median
Sep 2022
Cash from Financing (TTM) Benchmarks
| WuXi Biologics (Cayman) Inc | -360.36M |
| Zai Lab Ltd | -6.433M |
| I-MAB | -- |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Sinovac Biotech Ltd | -- |